Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
ACS Applied Materials & Interfaces
|
September 17, 2013
Preservation of cell viability and protein conformation on immobilization within nanofibers via electrospinning functionalized yeast
M Fatih Canbolat, Nimish Gera, Christina Tang, et al.
Molecular Cancer Therapeutics
|
April 29, 2024
MYTX-011: a pH-dependent anti-cMET antibody-drug conjugate designed for enhanced payload delivery to cMET expressing tumor cells
Nimish Gera, Kyle M Fitzgerald, Vijay Ramesh, et al.
Molecular Cancer Therapeutics
|
June 10, 2024
MYTX-011: A pH-Dependent Anti-c-MET Antibody-Drug Conjugate Designed for Enhanced Payload Delivery to c-MET-Expressing Tumor Cells
Nimish Gera, Kyle M Fitzgerald, Vijay Ramesh, et al.
Molecular Immunology
|
December 24, 2023
Characterization of the bispecific VHH antibody gefurulimab (ALXN1720) targeting complement component 5, and designed for low volume subcutaneous administration
Siddharth Jindal, Dennis Vestergaard Pedersen, Nimish Gera, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
ACS Applied Materials & Interfaces
|
September 17, 2013
Preservation of cell viability and protein conformation on immobilization within nanofibers via electrospinning functionalized yeast
M Fatih Canbolat, Nimish Gera, Christina Tang, et al.
Molecular Cancer Therapeutics
|
April 29, 2024
MYTX-011: a pH-dependent anti-cMET antibody-drug conjugate designed for enhanced payload delivery to cMET expressing tumor cells
Nimish Gera, Kyle M Fitzgerald, Vijay Ramesh, et al.
Molecular Cancer Therapeutics
|
June 10, 2024
MYTX-011: A pH-Dependent Anti-c-MET Antibody-Drug Conjugate Designed for Enhanced Payload Delivery to c-MET-Expressing Tumor Cells
Nimish Gera, Kyle M Fitzgerald, Vijay Ramesh, et al.
Molecular Immunology
|
December 24, 2023
Characterization of the bispecific VHH antibody gefurulimab (ALXN1720) targeting complement component 5, and designed for low volume subcutaneous administration
Siddharth Jindal, Dennis Vestergaard Pedersen, Nimish Gera, et al.
Page
of 2